Published in Learn Mem on October 02, 2002
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest (2004) 2.13
Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol (2007) 2.09
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet (2014) 1.56
Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem (2007) 1.50
Memory deficits are associated with impaired ability to modulate neuronal excitability in middle-aged mice. Learn Mem (2009) 1.16
Spines, plasticity, and cognition in Alzheimer's model mice. Neural Plast (2011) 1.06
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol Ther (2010) 1.05
Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease. J Neurosci (2010) 1.04
Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons. Am J Pathol (2005) 1.02
A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain. Acta Neuropathol (2009) 0.98
Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease. Alzheimers Res Ther (2013) 0.97
An update of animal models of Alzheimer disease with a reevaluation of plaque depositions. Exp Neurobiol (2013) 0.95
Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium? J Neuroimmune Pharmacol (2011) 0.94
Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats. Mol Med (2004) 0.94
Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease. Neuropsychopharmacology (2008) 0.93
Metallothionein and brain inflammation. J Biol Inorg Chem (2011) 0.90
Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines. Biochem Pharmacol (2014) 0.89
Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome. Neurobiol Learn Mem (2007) 0.88
Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis. Alzheimers Res Ther (2012) 0.87
Normal cognition in transgenic BRI2-Aβ mice. Mol Neurodegener (2013) 0.86
Preserved fronto-striatal plasticity and enhanced procedural learning in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe. Learn Mem (2004) 0.84
Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease. J Alzheimers Dis (2007) 0.83
Preventing formation of reticulon 3 immunoreactive dystrophic neurites improves cognitive function in mice. J Neurosci (2013) 0.82
Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease. Front Behav Neurosci (2014) 0.82
Rodent models for Alzheimer's disease drug discovery. Expert Opin Drug Discov (2015) 0.82
Differences in memory development among C57BL/6NCrl, 129S2/SvPasCrl, and FVB/NCrl mice after delay and trace fear conditioning. Comp Med (2014) 0.77
REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer's disease mouse model. Sci Rep (2016) 0.75
Elevated emotional contagion in a mouse model of Alzheimer's disease is associated with increased synchronization in the insula and amygdala. Sci Rep (2017) 0.75
A novel operant testing regimen for multi-construct cognitive characterization of a murine model of Alzheimer's amyloid-related behavioral impairment. Neurobiol Learn Mem (2011) 0.75
Mechanisms of Alzheimer's Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors. Clin Psychopharmacol Neurosci (2017) 0.75
Automated Operant Conditioning in the Mouse Home Cage. Front Neural Circuits (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci (1992) 11.73
Modality-specific retrograde amnesia of fear. Science (1992) 9.36
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature (2001) 7.35
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci (1996) 7.19
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science (1984) 6.86
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA (2000) 6.55
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A (1997) 5.66
APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol (1997) 4.29
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci (1999) 3.85
The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol (1998) 3.45
Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res (1997) 3.27
The dorsal hippocampus is essential for context discrimination but not for contextual conditioning. Behav Neurosci (1998) 2.86
Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol (1998) 2.85
Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature (1997) 2.44
Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain (2001) 2.05
Alzheimer's disease: genetic studies and transgenic models. Annu Rev Genet (1998) 1.93
Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci U S A (1995) 1.77
Learning and memory in transgenic mice modeling Alzheimer's disease. Learn Mem (2002) 1.76
Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. Learn Mem (1999) 1.76
Neurotoxic basolateral amygdala lesions impair learning and memory but not the performance of conditional fear in rats. J Neurosci (1999) 1.73
Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem (1998) 1.68
The origins of Alzheimer disease: a is for amyloid. JAMA (2000) 1.67
Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci (2001) 1.65
The limbic system in Alzheimer's disease. A neuropathologic investigation. Am J Pathol (1976) 1.64
Apolipoprotein E and cognitive performance. Nature (2000) 1.64
Overtraining does not mitigate contextual fear conditioning deficits produced by neurotoxic lesions of the basolateral amygdala. J Neurosci (1998) 1.63
The amygdala and fear conditioning: has the nut been cracked? Neuron (1996) 1.63
Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology (1990) 1.58
Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem (2002) 1.54
Dissociating context and space within the hippocampus: effects of complete, dorsal, and ventral excitotoxic hippocampal lesions on conditioned freezing and spatial learning. Behav Neurosci (1999) 1.49
Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res (1999) 1.34
Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol (1998) 1.29
Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron (2000) 1.24
Conditioning and contextual retrieval in hippocampal rats. Behav Neurosci (1991) 1.20
Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry (1997) 1.17
Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci (2001) 1.17
Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction. Neurology (1991) 1.13
Amygdala, hippocampus and discriminative fear conditioning to context. Behav Brain Res (2000) 1.13
Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience (2001) 1.08
Amygdala cell loss and atrophy in Alzheimer's disease. Ann Neurol (1992) 1.07
Impaired fear conditioning in Alzheimer's disease. Neuropsychologia (2002) 1.06
The startled seahorse: is the hippocampus necessary for contextual fear conditioning? Trends Cogn Sci (1998) 1.03
Amygdalar volume and emotional memory in Alzheimer's disease. Am J Psychiatry (1999) 1.02
Discriminative fear conditioning to context expressed by multiple measures of fear in the rat. Behav Brain Res (1999) 1.02
Relative sparing of emotionally influenced memory in Alzheimer's disease. Neuroreport (2000) 1.01
Perception of emotion in frontotemporal dementia and Alzheimer disease. Alzheimer Dis Assoc Disord (1999) 1.01
beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience (2001) 1.00
The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by beta-Secretase. J Biol Chem (2000) 0.99
Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport (1991) 0.97
The role of the entorhinal cortex in two forms of spatial learning and memory. Exp Brain Res (2001) 0.97
Memory enhancement for emotional stimuli is impaired in early Alzheimer's disease. Neuropsychology (2000) 0.95
Alzheimer patients report less pain intensity and pain affect than non-demented elderly. Psychiatry (1999) 0.92
Genes, models and Alzheimer's disease. Trends Genet (2001) 0.87
Alzheimer's disease in man and transgenic mice: females at higher risk. Am J Pathol (2001) 0.86
Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease. J Mol Neurosci (2000) 0.86
Contextual fear conditioning is disrupted by lesions of the subcortical, but not entorhinal, connections to the hippocampus. Exp Brain Res (2001) 0.84
Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice. Am J Pathol (2002) 0.83
Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor. Neurosci Lett (2000) 0.77
Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol Psychiatry (2006) 3.21
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain (2007) 2.96
PKMzeta maintains spatial, instrumental, and classically conditioned long-term memories. PLoS Biol (2008) 2.58
Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction. J Neurosci (2005) 2.55
ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci (2009) 2.31
Reciprocal patterns of c-Fos expression in the medial prefrontal cortex and amygdala after extinction and renewal of conditioned fear. Learn Mem (2009) 2.03
Context-dependent neuronal activity in the lateral amygdala represents fear memories after extinction. J Neurosci (2003) 1.94
Neural and cellular mechanisms of fear and extinction memory formation. Neurosci Biobehav Rev (2012) 1.94
Hippocampal involvement in contextual modulation of fear extinction. Hippocampus (2007) 1.93
Hippocampal and prefrontal projections to the basal amygdala mediate contextual regulation of fear after extinction. J Neurosci (2011) 1.77
Electrical wind force-driven and dislocation-templated amorphization in phase-change nanowires. Science (2012) 1.74
Ventral hippocampal muscimol disrupts context-specific fear memory retrieval after extinction in rats. Hippocampus (2006) 1.73
Electrolytic lesions of the dorsal hippocampus disrupt renewal of conditional fear after extinction. Learn Mem (2005) 1.58
Factors regulating the effects of hippocampal inactivation on renewal of conditional fear after extinction. Learn Mem (2004) 1.57
In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. Brain (2013) 1.57
Intrinsic response of graphene vapor sensors. Nano Lett (2009) 1.50
Plasma sodium and subclinical left atrial enlargement in chronic kidney disease. Nephrol Dial Transplant (2013) 1.43
Functional anatomy of neural circuits regulating fear and extinction. Proc Natl Acad Sci U S A (2012) 1.38
Electrolytic lesions of the medial prefrontal cortex do not interfere with long-term memory of extinction of conditioned fear. Learn Mem (2006) 1.37
The central nucleus of the amygdala is essential for acquiring and expressing conditional fear after overtraining. Learn Mem (2007) 1.37
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood (2014) 1.32
Auditory-evoked spike firing in the lateral amygdala and Pavlovian fear conditioning: mnemonic code or fear bias? Neuron (2003) 1.29
Differential roles for hippocampal areas CA1 and CA3 in the contextual encoding and retrieval of extinguished fear. Learn Mem (2008) 1.29
Aversive stimuli differentially modulate real-time dopamine transmission dynamics within the nucleus accumbens core and shell. J Neurosci (2012) 1.28
Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res (2002) 1.27
Pretraining NMDA receptor blockade in the basolateral complex, but not the central nucleus, of the amygdala prevents savings of conditional fear. Behav Neurosci (2003) 1.27
Lysosomal phospholipase A2 and phospholipidosis. Mol Cell Biol (2006) 1.23
Social modulation of learning in rats. Learn Mem (2009) 1.22
Single-unit activity in the medial prefrontal cortex during immediate and delayed extinction of fear in rats. PLoS One (2010) 1.19
Uncoupling protein-2 protects endothelial function in diet-induced obese mice. Circ Res (2012) 1.19
A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Stat Med (2004) 1.18
High yield preparation of macroscopic graphene oxide membranes. J Am Chem Soc (2009) 1.17
NMDA receptors are essential for the acquisition, but not expression, of conditional fear and associative spike firing in the lateral amygdala. Eur J Neurosci (2004) 1.16
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging (2010) 1.16
NMDA receptor antagonism in the basolateral but not central amygdala blocks the extinction of Pavlovian fear conditioning in rats. Eur J Neurosci (2010) 1.13
Monocarboxylate transporter (MCT) mediates the transport of gamma-hydroxybutyrate in human kidney HK-2 cells. Pharm Res (2007) 1.05
Individual variation in the propensity to attribute incentive salience to an appetitive cue predicts the propensity to attribute motivational salience to an aversive cue. Behav Brain Res (2011) 1.05
Retrospective comparison of titanium elastic nail (TEN) and reconstruction plate repair of displaced midshaft clavicular fractures. J Shoulder Elbow Surg (2011) 1.05
Early extinction after fear conditioning yields a context-independent and short-term suppression of conditional freezing in rats. Learn Mem (2009) 1.04
Single prolonged stress disrupts retention of extinguished fear in rats. Learn Mem (2012) 1.03
Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol Behav (2004) 1.03
Synergistic effects of Munc18a and X11 proteins on amyloid precursor protein metabolism. J Biol Chem (2002) 1.01
The secretion and uptake of lysosomal phospholipase A2 by alveolar macrophages. J Immunol (2008) 1.00
Strain difference in the effect of infralimbic cortex lesions on fear extinction in rats. Behav Neurosci (2010) 0.98
Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease. Exp Neurol (2012) 0.98
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Arch Neurol (2010) 0.97
ApoE receptor 2 regulates synapse and dendritic spine formation. PLoS One (2011) 0.96
Medial prefrontal cortex activation facilitates re-extinction of fear in rats. Learn Mem (2011) 0.95
Nuclear disconnection within the amygdala reveals a direct pathway to fear. Learn Mem (2009) 0.94
Characterization of monocarboxylate transport in human kidney HK-2 cells. Mol Pharm (2006) 0.94
Long-term potentiation as a substrate for memory: evidence from studies of amygdaloid plasticity and Pavlovian fear conditioning. Hippocampus (2002) 0.93
PPARδ activation protects endothelial function in diabetic mice. Diabetes (2012) 0.92
Associative structure of fear memory after basolateral amygdala lesions in rats. Behav Neurosci (2008) 0.92
X11alpha impairs gamma- but not beta-cleavage of amyloid precursor protein. J Neurochem (2004) 0.92
Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease. J Neurochem (2012) 0.91
Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice. Brain Res (2011) 0.91
The bed nucleus of the stria terminalis is required for the expression of contextual but not auditory freezing in rats with basolateral amygdala lesions. Neurobiol Learn Mem (2010) 0.90
Fear extinction in rodents. Curr Protoc Neurosci (2009) 0.89
Lesions of the entorhinal cortex or fornix disrupt the context-dependence of fear extinction in rats. Behav Brain Res (2008) 0.88
The cytoplasmic adaptor protein X11alpha and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement. FASEB J (2009) 0.88
X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice. Neurobiol Dis (2009) 0.87
NaHS relaxes rat cerebral artery in vitro via inhibition of l-type voltage-sensitive Ca2+ channel. Pharmacol Res (2011) 0.87
Deep sequencing and microarray hybridization identify conserved and species-specific microRNAs during somatic embryogenesis in hybrid yellow poplar. PLoS One (2012) 0.86
Animal models of fear relapse. ILAR J (2014) 0.85
A tetra(ethylene glycol) derivative of benzothiazole aniline enhances Ras-mediated spinogenesis. J Neurosci (2013) 0.85
Hitting Ras where it counts: Ras antagonism in the basolateral amygdala inhibits long-term fear memory. Eur J Neurosci (2006) 0.85
ELISA analysis of beta-secretase cleavage of the Swedish amyloid precursor protein in the secretory and endocytic pathways. J Neurochem (2002) 0.85
Validation of consensus panel diagnosis in dementia. Arch Neurol (2010) 0.85
Estrogenic effects of the herbal formula, menoprogen, in ovariectomized rats. Biol Pharm Bull (2010) 0.84
Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Cancer Lett (2009) 0.84
Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice. Am J Pathol (2002) 0.83
Enhancement of auditory fear conditioning after housing in a complex environment is attenuated by prior treatment with amphetamine. Learn Mem (2005) 0.83
Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation (2010) 0.82
Dynamic amino acid increases in the basolateral amygdala during acquisition and expression of conditioned fear. Eur J Neurosci (2006) 0.81
Glutamate receptors in the medial geniculate nucleus are necessary for expression and extinction of conditioned fear in rats. Neurobiol Learn Mem (2009) 0.81
Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions. Neurocase (2012) 0.81
Detection of hypopharyngeal squamous cell carcinoma using serum proteomics. Acta Otolaryngol (2006) 0.80
A pilot observational study to assess the safety and efficacy of Menoprogen for the management of menopausal symptoms in Chinese women. J Altern Complement Med (2009) 0.80
The relevance of the anatomical basis of fracture for the subsequent treatment of the anterior humeral circumflex artery and the axillary nerve. Int Orthop (2011) 0.80
Perovskite-supported palladium for methane oxidation - structure-activity relationships. Chimia (Aarau) (2012) 0.80
Mild illness in avian influenza A(H7N9) virus-infected poultry worker, Huzhou, China, April 2013. Emerg Infect Dis (2013) 0.79
Triple endobuttton technique for the treatment of acute complete acromioclavicular joint dislocations: preliminary results. Int Orthop (2010) 0.79
The amygdala is not necessary for unconditioned stimulus inflation after Pavlovian fear conditioning in rats. Learn Mem (2009) 0.79
Ovarian failure-resistant effects of catalpol in aged female rats. Biol Pharm Bull (2014) 0.79
Capsaicinoids lower plasma cholesterol and improve endothelial function in hamsters. Eur J Nutr (2012) 0.78
[Effects of Xiaotan Sanjie Decoction-containing serum on proliferation and apoptosis of human gastric cancer cells MKN-45]. Zhong Xi Yi Jie He Xue Bao (2010) 0.78
Aqueous extract of Astragali Radix ameliorates proteinuria in adriamycin nephropathy rats through inhibition of oxidative stress and endothelial nitric oxide synthase. J Ethnopharmacol (2010) 0.78
ApoE mimetic peptide decreases Abeta production in vitro and in vivo. Mol Neurodegener (2010) 0.78
Herbal formula menoprogen alters insulin-like growth factor-1 and insulin-like growth factor binding protein-1 levels in the serum and ovaries of an aged female rat model of menopause. Menopause (2015) 0.78
A novel fluorescence derivatization method combined with HPLC for determining the activities of endogenous caspase. Analyst (2012) 0.78
Clinical Features and Treatment Outcomes of Childhood Autoimmune Hemolytic Anemia: A Retrospective Analysis of 68 Cases. J Pediatr Hematol Oncol (2016) 0.77
[Effects of Fuzheng Huayu Decoction on plasma proteome in cirrhosis: preliminary experimental study with rats]. Zhonghua Yi Xue Za Zhi (2007) 0.77
Phenylbutyric acid protects against spatial memory deficits in a model of repeated electroconvulsive therapy. Curr Neurovasc Res (2014) 0.77
Inherited dementias. Neurol Clin (2002) 0.76
Ubiquitination signals critical to regulatory T cell development and function. Int Immunopharmacol (2013) 0.76
Visualization and quantitation of fetal movements by real-time three-dimensional ultrasound with live xPlane imaging in the first trimester of pregnancy. Croat Med J (2016) 0.75
Progressive Semisupervised Learning of Multiple Classifiers. IEEE Trans Cybern (2017) 0.75
[Study on morphology of the pollen of 4 species from Geranium in Heilongjiang Province]. Zhong Yao Cai (2002) 0.75
Allergy immunotherapy as an early intervention in patients with child-onset atopic asthma. Int Arch Allergy Immunol (2005) 0.75
Pharmacist-developed sedation protocol and impact on ventilator days. J Pharm Pract (2012) 0.75